Document is current
Any future updates will be listed below
-
Authors
Moreira, Rodrigo O. https://orcid.org/0000-0003-1561-2926
Nicodemus, Nemencio A. Jr.
Comlekci, Abdurrahman
Yu, Miao
Almalki, Mussa H.
-
Funding
Funding for this research was provided by:
Servier
- License Information
-
More Information
Article History
Received: 6 August 2025
Accepted: 1 October 2025
First Online: 1 November 2025
Declarations
:
: Rodrigo Moreira: Fees as speaker from Servier, Novo Nordisk, AstraZeneca, Bayer, Eli Lilly. Nemencio A Nicodemus Jr.: Speaker honoraria from Servier, AstraZeneca, Boehringer Ingelheim and Taisho. Abdurrahman Comlekci: No conflict of interest. Miao Yu: Honoraria for speaker engagement from MSD, Novo Nordisk, Sanofi, Eli Lilly, Novartis, Servier and AstraZeneca; has served on Advisory boards for Novo Nordisk, Sanofi, MSD, Eli Lilly, Roche and AstraZeneca. Mussa H Almalki: No conflict of interest.
: The study was performed in accordance with the Helsinki Declaration of 1964, and its later amendments. Ethics approval was received from appropriate committees in each of the countries where the study was conducted, representing all the sites that were included (Supplementary Table ). Informed consent for medical record review and the use of research-related health information was obtained in accordance with local regulations.
